Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6408 posts found.

china_red_flag

US Department of Justice looking into Pfizer’s operations in China

November 6, 2020 Medical Communications

The US Department of Justice and the US Securities and Exchange Commission (SEC) are investigating Pfizer’s operations in China after …
News
novartis_outside_1

Novartis’ arthritis therapy shows no efficacy in hospitalised COVID-19 patients

November 6, 2020 Medical Communications, Research and Development COVID-19, Novatis, canakinumab

Novartis has revealed that its arthritis drug, theinterleukin-1 beta inhibitor canakinumab, in combination with standard of care (SoC), failed to …
News
top_10_image_2

Pharmafile.com’s weekly COVID-19 news round-up

November 6, 2020 Medical Communications COVID, COVID-19, EC, FDA, coronavirus

The top ten news stories this week focus on regulatory approvals as the European Commission has approved GlaxoSmithKline’s Zeljula as …
News
tt

How the US election could affect the pharmaceutical industry

November 4, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Donald Trump, Joe Biden, Trump, US, US election 2020, pharma

The US is one of the most lucrative markets for the pharmaceutical industry. This is a country where a lack of …
Feature
covid_cell_1

Pharmafile.com’s weekly COVID-19 news round-up

November 4, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, GSK, Sanofi, UK, US, remdesivir

As European nations fall one by one back into lockdown, hopes weigh heavily on a vaccine to pave a path …
News
nice_new_london_office_internal_3_web

NICE recommends Novo’s liraglutide for management of obesity and non-diabetic hyperglycaemia

October 30, 2020 Medical Communications, Sales and Marketing NICE, Novo Nordisk, liraglutide

Novo Nordisk’s pre-filled injection Saxenda (liraglutide) has received the backing of drug watchdog NICE, meaning it will now be made …
News
shutterstock_87495637

AstraZeneca jettisons two heart drugs to Cheplapharm in $400m deal

October 30, 2020 Manufacturing and Production, Medical Communications, Sales and Marketing AstraZeneca, Cheplapharm

AstraZeneca is set to sell the rights to its AT1 subtype angiotensin II receptor antagonist Atacand (candesartan cilexetil) and Atacand …
News
800px-european_commission_flags_1

EU approves Zejula as a first-line monotherapy maintenance treatment in advanced ovarian cancer

October 30, 2020 Medical Communications

The European Commission has approved GlaxoSmithKline’s Zeljula as a first line monotherapy maintenance treatment for adult patients with ovarian cancer …
News
49798220211_23b94b0fb8_b

New study suggests UK Government’s ‘Eat Out to Help Out’ scheme increased coronavirus infection rates

October 30, 2020 Medical Communications

The Eat Out to Help Out scheme contributed to a significant rise in new coronavirus cases according to a study …
News
top_10_image_2

Top Ten most popular articles on Pharmafile.com this week

October 30, 2020 Medical Communications

The top ten news stories this week focus on COVID-19 studies, as new research has found that over 80% of …
News
tumour-infiltrating_lymphocytes_-_2_--_very_high_mag

NICE says test people with womb cancer for Lynch syndrome

October 29, 2020 Medical Communications

New guidance from the National Institute of Health and Care Excellence says that women with womb cancer should be tested …
News
pharmafocus_november_2020_cover

The November 2020 issue of Pharmafocus is available to read free online now!

October 27, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Biden, Pharmafocus, Trump, UK, US election, brexit, pharma, remdesivir

The latest monthly edition of Pharmafocus is available to read for free online now!
News
me_and_calcin_at_aquarium_usa

Patient Experience: Living with Timothy syndrome

October 26, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Timoty syndrome, feature, patient experience, rare disease

Thirteen-year-old Calvin Muir lives with the ultra-rare genetic condition Timothy syndrome. Like many parents of rare disease patients, his mother …
Feature
brain_anatomy_medical_head_skull_digital_3_d_x_ray_xray_psychedelic_3720x2631_1

IBM and Pfizer designing AI model to predict onset of neurological diseases

October 23, 2020 Medical Communications

IBM has partnered with Pfizer to design an artificial intelligence model to predict the eventual onset of neurological diseases – …
News
fdaoutsideweb

FDA approves Gilead’s remdesivir for hospitalised COVID-19 patients

October 23, 2020 Medical Communications, Sales and Marketing COVID-19, FDA, Gilead, remdesivir

The FDA has approved Gilead’s antiviral therapy Veklury (remdesivir) for the treatment of hospitalised COVID-19 patients, making it the first …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026